Screening of selective histone deacetylase inhibitors by proteochemometric modeling.
about
When drug discovery meets web search: Learning to Rank for ligand-based virtual screeningProteochemometric modeling of the antigen-antibody interaction: new fingerprints for antigen, antibody and epitope-paratope interactionProteochemometric modeling in a Bayesian framework.Histone deacetylase (HDAC) inhibitory and antiproliferative activities of phenolic-rich extracts derived from the rhizome of Hydnophytum formicarum Jack.: sinapinic acid acts as HDAC inhibitor.Potassium channels: structures, diseases, and modulators.The nature of the GRE influences the screening for GR-activity enhancing modulators.The recent progress in proteochemometric modelling: focusing on target descriptors, cross-term descriptors and application scope.Proteochemometric model for predicting the inhibition of penicillin-binding proteins.Histone deacetylase inhibitory effect of Brazilian propolis and its association with the antitumor effect in Neuro2a cells.A phase II trial of valproic acid in patients with advanced, radioiodine-resistant thyroid cancers of follicular cell origin.Illuminating the origins of spectral properties of green fluorescent proteins via proteochemometric and molecular modeling.Energy-optimised pharmacophore approach to identify potential hotspots during inhibition of Class II HDAC isoforms.Proteochemometric Modeling of the Interaction Space of Carbonic Anhydrase and its Inhibitors: An Assessment of Structure-based and Sequence-based Descriptors.Finding the molecular scaffold of nuclear receptor inhibitors through high-throughput screening based on proteochemometric modelling.Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospects
P2860
Q27902275-E234B84E-0F97-468F-B1F8-82FD96F3D15AQ28546634-C285E51E-7715-45F2-B80E-9484438ACE11Q30086274-B4A6D756-AAF7-4CEE-912C-0CD08BC99B3FQ34992824-7F3FFDA2-C318-4622-89A4-151FDDE323BCQ38151974-3AC34AFA-1E36-4327-AD41-984E9BB95C49Q38697860-34B7A1AE-9E94-4CDE-B6CF-2070C1D38E4BQ38731960-F20BF0C2-700D-417C-AD27-D9EE2D55278BQ39108153-70257BDC-F18A-4226-B019-EE2E3CE80A06Q41729088-94438CE0-FEDC-4CDD-B99D-0F9C0927563CQ47160397-BC5C5FB1-1943-4FC3-8D45-AB4DF7DF1237Q50451269-2029C406-49B5-472F-A2C6-C38D67C38739Q50693776-B6F9D340-01BF-4CEF-8647-A9623F93E1E5Q51319882-F3C4E623-F181-4EC6-8B3B-35C9DACE592FQ52590560-0F463238-38D6-4F0D-9AF8-CF12C0E70F60Q54152494-652C83E0-37D5-4A8B-B5F7-6425B9009B6F
P2860
Screening of selective histone deacetylase inhibitors by proteochemometric modeling.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Screening of selective histone deacetylase inhibitors by proteochemometric modeling.
@ast
Screening of selective histone deacetylase inhibitors by proteochemometric modeling.
@en
type
label
Screening of selective histone deacetylase inhibitors by proteochemometric modeling.
@ast
Screening of selective histone deacetylase inhibitors by proteochemometric modeling.
@en
prefLabel
Screening of selective histone deacetylase inhibitors by proteochemometric modeling.
@ast
Screening of selective histone deacetylase inhibitors by proteochemometric modeling.
@en
P2093
P2860
P356
P1433
P1476
Screening of selective histone deacetylase inhibitors by proteochemometric modeling
@en
P2093
Dingfeng Wu
Qingchen Zhang
Yida Zhang
Zhiwei Cao
P2860
P2888
P356
10.1186/1471-2105-13-212
P50
P577
2012-08-22T00:00:00Z
P5875
P6179
1021848340